Spatial proteomics, selected as the 2024 Method of the Year by Nature Methods journal (1), is an emerging scientific discipline that focuses on studying proteins within their spatial contexts, ...
When Steve Carr, senior director of the Proteomics Platform at the Broad Institute of MIT and Harvard, began working in proteomics, the field was able to detect only the most abundant proteins in a ...
A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial proteomics and lipidomics easier to use – no coding required. C-COMPASS ...
Microglia are dynamic, tissue-resident immune cells in the central nervous system that perform diverse functions throughout brain development, adulthood and aging, as well as in neurodegenerative and ...
Bruker Corporation (Nasdaq: BRKR) announced the launch of CellScape™ XR, a next-generation spatial proteomics platform designed to advance the development of diagnostic and prognostic assays by ...
Spatial Biology has emerged as the latest discipline with a demonstrably transformative impact on advancing translational research. In particular, spatial proteomics focuses on the localized mapping ...
When Matthew Padula was diagnosed with a rare bladder cancer in 2020, he knew there was a challenging road ahead of him. As a researcher at the University of Technology Sydney, his first instinct was ...
Spatial omics is transforming how researchers understand tissue biology, revealing the complex interplay between cells in health and disease. While RNA expression studies provide important molecular ...
Proteomics—a term first coined in the mid-1990s—refers to the study of the complete set of proteins expressed in a cell, tissue, or organism. In contrast to genomics and transcriptomics, proteomics is ...
Breast ductal carcinoma in situ is a common non-invasive clinical finding that can progress to invasive breast cancer (IBC). Spatial proteomics can provide an additional dimension to our understanding ...
A global team of researchers at the Max Planck Institute of Biochemistry has made a discovery that has helped save the lives of patients suffering from toxic epidermal necrolysis. This rare but often ...